Private Equity

North America

United Airlines invests $15m in carbon capture platform Svante

Proceeds of United Airlines' investment will fund and support Svante's commercial-scale filter manufacturing facility in Vancouver.

2 min read · 30 March 2023

Birdseye raises C$500k in Drive Capital-backed pre-seed round

Birdseye is a Toronto-based all-in-one marketing analytics system for Shopify brands.

1 min read · 30 March 2023

Fred Wilson, Satya Patel, other notables back new firm Gutter Capital

The New York firm raised a debut fund of $25m to invest in companies that address affordability, economic mobility and climate change.

3 min read · 29 March 2023

Climate tech startup Carbon Neutral Club lands C$1.4m seed round

The round was led by Emend Vision Fund, Blue Vision Capital and Good News Ventures.

2 min read · 29 March 2023

Pulse Industrial snags VC financing led by Momenta

Based in Waterloo, Ontario, Pulse Industrial is a developer of an artificial intelligence platform focused on industrial equipment failure monitoring.

2 min read · 29 March 2023

Investors are hot for Torch Capital's sophomore fund

Torch Capital's focus on consumer products appears to have lit a fire with investors, as the New York venture firm has closed on more than $200 million, or three times more than it raised for its debut fund.

4 min read · 28 March 2023

Life sciences startup Cora Therapeutics raises C$1m in seed VC

Based in Toronto, Cora Therapeutics is the developer of DNA HALO, an advanced antioxidant formulation.

1 min read · 28 March 2023

PH7 Technologies lands $16m in Series A led by TDK, Pangaea

Based in Vancouver, PH7 Technologies is a developer of methodologies for sustainable extraction and refining of strategic metals.

2 min read · 28 March 2023

3E Nano nabs $4m seed to advance solar control tech for windows

Founded in 2015 as a spinout from the University of Toronto, 3E Nano is developing thermal energy control nano-coating to transform the window market.

2 min read · 28 March 2023

In brief: SR One beats target for sophomore biotech fund

SR One Capital Management, a transatlantic biotech VC firm that spun out of GlaxoSmithKline, has closed on more than $600 million for its second fund, beating its $500 million target.

1 min read · 28 March 2023

Showing 1,131 to 1,140 of 45,546 results
1…113115…1000